Bariatric surgery is linked to significantly fewer heart attacks and strokes

March 18, 2020

A nationwide study of nearly 7,500 people who are obese or severely obese has found that bariatric surgery is linked to significantly fewer heart attacks and strokes.

The study, which is published in the European Heart Journal [1] today (Thursday), found there were 60% fewer fatal and non-fatal heart attacks and stroke among 3,701 men and women who received bariatric surgery compared to the same number of patients who did not, during an average of 11 years following the surgery.

In addition, patients who had bariatric surgery lost significantly more weight (an average of over 10 kg more), and type 2 diabetes was more likely to improve to the point where the patients no longer required medication to maintain normal blood sugar levels.

Bariatric surgery involves restricting how much food the stomach can hold, usually by means of a gastric band that is placed around the stomach, or a gastric bypass that links the top part of the stomach to the small intestine. Both methods mean the patient does not need to eat so much to feel full, and the gastric bypass reduces the number of calories absorbed from food. [2]

Researchers at Imperial College London (UK) analysed data from the Clinical Practice Research Datalink (CPRD) database, which holds information on over 11 million patients from 674 general practice surgeries in the UK, dating from 1987 to the present. They extracted data on 3,701 patients who had a body mass index (BMI) of 35 kg/m2 or more, who had not suffered a heart attack or stroke when the study started and who had undergone bariatric surgery. They also looked at a control group of 3,701 patients who matched the first group in age, BMI and gender but who had not had bariatric surgery.

They adjusted for factors that could affect the results, such as high levels of cholesterol in the blood, smoking, alcohol and cocaine use, exercise and use of medications, such as statins, beta blockers and hormone replacement therapy. The average (median) age was 36 years in both groups; the average (median) BMI before surgery was 40.5 kg/m2 in the group that had bariatric surgery and 40.3 kg/m2 in the group that did not.

During follow-up, there were 37 fatal or non-fatal heart attacks or strokes in the bariatric surgery group and 93 in the non-surgery group.

Dr Maddalena Ardissino, academic foundation trainee at Imperial and joint first author of the EHJ paper, said: "The results of our study indicated that the rates of heart attacks and strokes were significantly lower in those who underwent bariatric surgery; specifically, we observed lower rates of heart attacks. This means that bariatric surgery was associated with a 1.5% reduction in the absolute risk of heart attacks or strokes; 62 patients would need to have bariatric surgery to prevent one heart attack or stroke. As this was a young group of patients, in whom we would expect to see fewer such events than in older patients, the reduction in the absolute risk has important clinical implications.

"Rates of acute ischaemic stroke were similar across the two groups, though very few events were recorded."

There was a 60% reduction in new diagnoses of heart failure during follow-up, 22 in the bariatric surgery group and 46 in the control group, and death from any cause was 80% lower among patients who had bariatric surgery compared to those who did not: 45 versus 182 deaths respectively.

Co-author, Peter Collins, Professor of Clinical Cardiology at the National Heart and Lung Institute at Imperial, said: "It's important to emphasise that this is a retrospective study and can only show there is an association between bariatric surgery and a reduced risk of heart attacks and strokes, not that the surgery causes the reduction in risk. Large, prospective trials are required to show causation. Nonetheless, the difference observed in cardiovascular events is striking, and it indicates that if a causative effect does indeed exist, its size has the potential to be very large and important.

"These findings call for increased awareness and increased uptake of bariatric surgery as a treatment step for patients with obesity who do not achieve significant weight loss on lifestyle and pharmacological therapy alone. This is important, as only a small minority of patients are offered the surgery and, among these, a minority actually undergo it. The rate has been estimated to be as low as 1%." [3]

Senior author, Mr Sanjay Purkayastha, a senior lecturer at Imperial and also a consultant bariatric surgeon at Imperial College Healthcare NHS Trust, said: "The results of this study, taken together with the wealth of emerging evidence on the benefits of bariatric surgery, not only on weight loss but also on the management and prevention of obesity-related health problems, call for a definitive shift in the perception of bariatric surgery, from what used to be seen as a 'bonus' or 'extra', almost as an aesthetic procedure undergone by only a minority of the eligible population, to a truly disease-preventing and standard of care procedure that should at least be offered sooner rather than later to eligible patients.

"GPs should consider earlier referral to derive greater benefits in their patients. Especially for patients with type 2 diabetes, as several prospective randomised studies have shown that bariatric surgery is significantly better, currently, compared to best medical management. Similar studies should be designed to further investigate the impact on heart attacks and strokes."

This is the largest study of bariatric patients so far, and the findings are likely to be generalisable to the whole of the UK and most Western countries because of the diverse nature of the UK population within the CPRD database. However, limitations include that because the average age of the patients was relatively low, there were few heart attacks and strokes, so the effect of surgery may be underestimated. In addition, other factors that could affect the results may be unknown or unmeasurable.

[1] "The effect of bariatric surgery on long-term cardiovascular outcomes: a nationwide nested cohort study", by Osama Moussa et al. European Heart Journal. doi:10.1093/eurheartj/ehaa069

[2] Risks of bariatric surgery are low: the chances of death are around one in 1400 patients; other rare complications include blood clots, infections and ulcers; the overall risk of complications is about one in ten, but most tend to be minor.

[3] In the UK, people are eligible for bariatric surgery if they have tried and failed other forms of weight loss for at least six month to a year, have a BMI of 40 kg/m2 or more or more if they have no other health conditions, or 35 kg/m2 if they do have other health problems. In patients of Asian or south Asian origin the qualifying BMIs are 2.5 kg/m2 less. However, there are large variations in awareness of and access to bariatric surgery, both within countries and between countries.

European Society of Cardiology

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to